Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Other Non-Current Assets (2016 - 2026)

Avanos Medical's Other Non-Current Assets history spans 13 years, with the latest figure at $31.5 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 35.78% to $31.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $31.5 million, a 35.78% increase, with the full-year FY2025 number at $31.5 million, up 35.78% from a year prior.
  • Other Non-Current Assets hit $31.5 million in Q4 2025 for Avanos Medical, up from $29.3 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for AVNS hit a ceiling of $182.3 million in Q4 2022 and a floor of $11.0 million in Q2 2021.
  • Historically, Other Non-Current Assets has averaged $30.4 million across 5 years, with a median of $18.8 million in 2023.
  • Biggest five-year swings in Other Non-Current Assets: soared 1004.85% in 2022 and later plummeted 89.41% in 2023.
  • Tracing AVNS's Other Non-Current Assets over 5 years: stood at $16.5 million in 2021, then soared by 1004.85% to $182.3 million in 2022, then tumbled by 89.41% to $19.3 million in 2023, then grew by 20.21% to $23.2 million in 2024, then soared by 35.78% to $31.5 million in 2025.
  • Business Quant data shows Other Non-Current Assets for AVNS at $31.5 million in Q4 2025, $29.3 million in Q3 2025, and $25.7 million in Q2 2025.